Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
diabetes drugs
Pharma
Lilly cuts revenue guidance as momentum stalls for tirzepatide
Sales of Eli Lilly’s tirzepatide products fell far short of expectations in Q3, leading the juggernaut company to reduce its annual revenue guidance.
Kevin Dunleavy
Oct 30, 2024 9:47am
Insulet unveils $200M insulin delivery device production site
Aug 15, 2024 8:34am
AZ to drop $26.5M in China for new production line: report
Jan 18, 2024 9:09am
Lilly hits out against using Zepbound for ‘cosmetic weight loss’
Jan 5, 2024 6:00am
AZ's Dobber talks SGTL2, GLP-1 clash in heart failure
Aug 29, 2023 1:30pm
UNDBIO earmarks $100M to build insulin plant in West Virginia
Apr 13, 2023 10:20am
